Abstract

Objective: This experimental study was designed to determine the changes in tissue levels of malondialdehyde, end-product of lipid peroxidation (MDA), reduced glutathione (GSH) and xanthine oxidase (XO) and the effect of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE) on these metabolite levels after adnexal torsion–detorsion model in rats. Method: Forty adult female albino rats were divided into five groups: basal control ( n = 8), sham operation ( n = 8), torsion–detorsion plus saline ( n = 8), torsion–detorsion plus CAPE ( n = 8). and only torsion ( n = 8). Rats in the sham operation group underwent a surgical procedure similar to the other groups but the adnexa was not torsioned. Rats in the torsion group were killed after 360° clockwise adnexal torsion for 3 h and ovaries were harvested. CAPE was injected intraperitoneally 30 min before detorsion in the CAPE/detorsion group and saline was administered in the saline/detorsion group. After 3 h of adnexal detorsion, the rats in both groups were killed and adnexa were surgically removed. Results: MDA levels and XO activities in torsion–detorsion plus saline group increased significantly when compared to basal control, torsion and sham operation groups ( P < 0.001). In the CAPE group, MDA levels and XO activities were lower than those of torsion–detorsion plus saline group, and differences between the two groups were statistically significant ( P < 0.001). GSH levels in torsion–detorsion plus saline group were decreased significantly when compared to basal control and sham operation groups ( P < 0.001). GSH levels in the CAPE group were higher than those of torsion–detorsion plus saline group, and differences between the two groups were statistically significant ( P < 0.004). Morphologically, polymorphonuclear leukocytic infiltration and vascular dilatation were obvious in the ischemia-reperfusion damaged ovary, a change partially reversed by CAPE. Conclusions: These results suggest that administration of CAPE has beneficial effects in the prevention of ischemia-reperfusion injury of the ovaries.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.